Annual Planning
Samples will be delivered no later than 1 day before the start date of the relevant round. If this is not the case, please contact us.
Section: General Chemistry
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| ACE | 2024.1 | 2024-01-01 | 2024-07-01 |
| ACE | 2024.2 | 2024-07-01 | 2025-01-01 |
| AP-isoenzymes | 2024.1 | 2024-01-01 | 2024-06-29 |
| AP-isoenzymes | 2024.2 | 2024-06-17 | 2024-12-14 |
| Bile acid salts | 2024.1 | 2024-01-01 | 2024-04-01 |
| Bile acid salts | 2024.2 | 2024-04-01 | 2024-07-01 |
| Bile acid salts | 2024.3 | 2024-07-01 | 2024-10-01 |
| Bile acid salts | 2024.4 | 2024-10-01 | 2025-01-01 |
| Bloodgas Parameters | 2024.1 | 2024-01-01 | 2024-04-01 |
| Bloodgas Parameters | 2024.2 | 2024-04-01 | 2024-07-01 |
| Bloodgas Parameters | 2024.3 | 2024-07-01 | 2024-10-01 |
| Bloodgas Parameters | 2024.4 | 2024-10-01 | 2025-01-01 |
| Cardiac markers | 2024.1 | 2024-01-01 | 2024-04-01 |
| Cardiac markers | 2024.2 | 2024-04-01 | 2024-07-01 |
| Cardiac markers | 2024.3 | 2024-07-01 | 2024-10-01 |
| Cardiac markers | 2024.4 | 2024-10-01 | 2025-01-01 |
| CDT | 2024.1 | 2024-01-01 | 2024-07-01 |
| CDT | 2024.2 | 2024-07-01 | 2025-01-01 |
| Clinical Chemistry, blood | 2024.1 | 2024-01-01 | 2024-04-01 |
| Clinical Chemistry, blood | 2024.2 | 2024-04-01 | 2024-07-01 |
| Clinical Chemistry, blood | 2024.3 | 2024-07-01 | 2024-10-01 |
| Clinical Chemistry, blood | 2024.4 | 2024-10-01 | 2025-01-01 |
| Clinical Chemistry, urine qualitative | 2024.1 | 2024-01-31 | 2024-02-07 |
| Clinical Chemistry, urine qualitative | 2024.2 | 2024-04-17 | 2024-04-24 |
| Clinical Chemistry, urine qualitative | 2024.3 | 2024-08-14 | 2024-08-21 |
| Clinical Chemistry, urine qualitative | 2024.4 | 2024-11-06 | 2024-11-13 |
| Clinical Chemistry, urine quantitative | 2024.1 | 2024-01-01 | 2024-04-01 |
| Clinical Chemistry, urine quantitative | 2024.2 | 2024-04-01 | 2024-07-01 |
| Clinical Chemistry, urine quantitative | 2024.3 | 2024-07-01 | 2024-10-01 |
| Clinical Chemistry, urine quantitative | 2024.4 | 2024-10-01 | 2025-01-01 |
| Ethanol in serum | 2024.1 | 2024-01-01 | 2024-04-01 |
| Ethanol in serum | 2024.2 | 2024-04-01 | 2024-07-01 |
| Ethanol in serum | 2024.3 | 2024-07-01 | 2024-10-01 |
| Ethanol in serum | 2024.4 | 2024-10-01 | 2025-01-01 |
| Feces-chemistry | 2024.1 | 2024-01-01 | 2024-07-01 |
| Feces-chemistry | 2024.2 | 2024-07-01 | 2025-01-01 |
| Fetal fibronectine or alternative | 2024.1 | 2024-04-17 | 2024-04-24 |
| Fetal fibronectine or alternative | 2024.2 | 2024-11-06 | 2024-11-13 |
| Fructosamin | 2024.1 | 2024-01-01 | 2024-04-01 |
| Fructosamin | 2024.2 | 2024-04-01 | 2024-07-01 |
| Fructosamin | 2024.3 | 2024-07-01 | 2024-10-01 |
| Fructosamin | 2024.4 | 2024-10-01 | 2025-01-01 |
| HbA1c | 2024.1 | 2024-01-01 | 2024-12-28 |
| HbA1c whole blood | 2024.1 | 2024-01-17 | 2024-01-20 |
| HbA1c whole blood | 2024.2 | 2024-03-06 | 2024-03-09 |
| HbA1c whole blood | 2024.3 | 2024-05-15 | 2024-05-18 |
| HbA1c whole blood | 2024.4 | 2024-07-03 | 2024-07-06 |
| HbA1c whole blood | 2024.5 | 2024-09-11 | 2024-09-14 |
| HbA1c whole blood | 2024.6 | 2024-10-23 | 2024-10-26 |
| Hemoximetry | 2024.1 | 2024-01-01 | 2024-07-01 |
| Hemoximetry | 2024.2 | 2024-07-01 | 2025-01-01 |
| Homocystein | 2024.1 | 2024-01-01 | 2024-07-01 |
| Homocystein | 2024.2 | 2024-07-01 | 2025-01-01 |
| Inflammation markers | 2024.1 | 2024-01-01 | 2024-04-01 |
| Inflammation markers | 2024.2 | 2024-04-01 | 2024-07-01 |
| Inflammation markers | 2024.3 | 2024-07-01 | 2024-10-01 |
| Inflammation markers | 2024.4 | 2024-10-01 | 2025-01-01 |
| Lipids | 2024.1 | 2024-01-01 | 2024-04-01 |
| Lipids | 2024.2 | 2024-04-01 | 2024-07-01 |
| Lipids | 2024.3 | 2024-07-01 | 2024-10-01 |
| Lipids | 2024.4 | 2024-10-01 | 2025-01-01 |
| Neonatal Bilirubin | 2024.1 | 2024-01-01 | 2024-04-01 |
| Neonatal Bilirubin | 2024.2 | 2024-04-01 | 2024-07-01 |
| Neonatal Bilirubin | 2024.3 | 2024-07-01 | 2024-10-01 |
| Neonatal Bilirubin | 2024.4 | 2024-10-01 | 2025-01-01 |
| Occult blood in feces | 2024.1 | 2024-01-01 | 2024-04-01 |
| Occult blood in feces | 2024.2 | 2024-04-01 | 2024-07-01 |
| Occult blood in feces | 2024.3 | 2024-07-01 | 2024-10-01 |
| Occult blood in feces | 2024.4 | 2024-10-01 | 2025-01-01 |
| Pilot Cystatin C, serum | 2024.1 | 2024-03-11 | 2024-04-06 |
| Pilot Cystatin C, serum | 2024.2 | 2024-03-11 | 2024-04-06 |
| Pilot Cystatin C, serum | 2024.4 | 2024-09-09 | 2024-09-30 |
| Pilot Cystatin C, serum | 2024.3 | 2024-09-09 | 2024-09-30 |
| Pilot urine sediment | 2024.1 | 2024-06-11 | 2024-06-19 |
| Pilot urine sediment | 2024.2 | 2024-10-01 | 2024-10-09 |
| POCT in whole blood | 2024.1 | 2024-01-31 | 2024-02-07 |
| POCT in whole blood | 2024.2 | 2024-04-17 | 2024-04-24 |
| POCT in whole blood | 2024.3 | 2024-08-21 | 2024-08-28 |
| POCT in whole blood | 2024.4 | 2024-11-06 | 2024-11-13 |
| Porphyrines in urine | 2024.1 | 2024-01-01 | 2024-03-31 |
| Porphyrines in urine | 2024.2 | 2024-04-01 | 2024-06-30 |
| Porphyrines in urine | 2024.3 | 2024-07-01 | 2024-09-29 |
| Porphyrines in urine | 2024.4 | 2024-09-30 | 2024-12-29 |
| Trace Elements Serum | 2024.1 | 2024-04-01 | 2025-04-01 |
| Trace Elements Urine | 2024.1 | 2024-04-01 | 2025-04-01 |
| Trace Elements Whole blood | 2024.1 | 2024-04-01 | 2025-04-01 |
| Urine sediment (qualitative) | 2024.1 | 2024-03-21 | 2024-04-20 |
| Urine sediment (qualitative) | 2024.2 | 2024-05-29 | 2024-06-28 |
| Urine sediment (qualitative) | 2024.3 | 2024-08-29 | 2024-09-28 |
| Urine sediment (qualitative) | 2024.4 | 2024-11-28 | 2024-12-28 |
| Vitamin A/E and beta-carotene | 2024.1 | 2024-01-01 | 2024-07-01 |
| Vitamin A/E and beta-carotene | 2024.2 | 2024-07-01 | 2025-01-01 |
| Vitamin B1/B6 | 2024.1 | 2024-01-01 | 2024-07-01 |
| Vitamin B1/B6 | 2024.2 | 2024-07-01 | 2025-01-01 |
Section: Bacteriology / Mycology
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Bacteriology | 2024.1 | 2024-01-30 | 2024-02-21 |
| Bacteriology | 2024.2 | 2024-04-02 | 2024-04-24 |
| Bacteriology | 2024.3 | 2024-05-14 | 2024-06-05 |
| Bacteriology | 2024.4 | 2024-10-01 | 2024-10-23 |
| Bacteriology | 2024.5 | 2024-11-19 | 2024-12-11 |
| Mycobacteriology | 2024.1 | 2024-09-17 | 2024-12-19 |
| Mycology | 2024.1 | 2024-03-11 | 2024-05-12 |
| Mycology | 2024.2 | 2024-09-24 | 2024-11-25 |
Section: Endocrinology
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Hormones in Saliva | 2024.1 | 2024-01-01 | 2024-03-01 |
| Hormones in Saliva | 2024.2 | 2024-03-01 | 2024-05-01 |
| Hormones in Saliva | 2024.3 | 2024-05-01 | 2024-07-01 |
| Hormones in Saliva | 2024.4 | 2024-07-01 | 2024-09-01 |
| Hormones in Saliva | 2024.5 | 2024-09-01 | 2024-11-01 |
| Hormones in Saliva | 2024.6 | 2024-11-01 | 2025-01-01 |
| Hormones in Serum | 2024.1 | 2024-01-01 | 2024-03-01 |
| Hormones in Serum | 2024.2 | 2024-03-01 | 2024-05-01 |
| Hormones in Serum | 2024.3 | 2024-05-01 | 2024-07-01 |
| Hormones in Serum | 2024.4 | 2024-07-01 | 2024-09-01 |
| Hormones in Serum | 2024.5 | 2024-09-01 | 2024-11-01 |
| Hormones in Serum | 2024.6 | 2024-11-01 | 2025-01-01 |
| Hormones in Urine | 2024.1 | 2024-01-01 | 2024-03-01 |
| Hormones in Urine | 2024.2 | 2024-03-01 | 2024-05-01 |
| Hormones in Urine | 2024.3 | 2024-05-01 | 2024-07-01 |
| Hormones in Urine | 2024.4 | 2024-07-01 | 2024-09-01 |
| Hormones in Urine | 2024.5 | 2024-09-01 | 2024-11-01 |
| Hormones in Urine | 2024.6 | 2024-11-01 | 2025-01-01 |
| Tumor markers | 2024.1 | 2024-01-01 | 2024-03-01 |
| Tumor markers | 2024.2 | 2024-03-01 | 2024-05-01 |
| Tumor markers | 2024.3 | 2024-05-01 | 2024-07-01 |
| Tumor markers | 2024.4 | 2024-07-01 | 2024-09-01 |
| Tumor markers | 2024.5 | 2024-09-01 | 2024-11-01 |
| Tumor markers | 2024.6 | 2024-11-01 | 2025-01-01 |
Section: Drug analysis and toxicology (KKGT)
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Alcohols/GHB | 2024.1 | 2024-02-14 | 2024-03-22 |
| Alcohols/GHB | 2024.2 | 2024-05-08 | 2024-06-14 |
| Alcohols/GHB | 2024.3 | 2024-08-14 | 2024-09-20 |
| Alcohols/GHB | 2024.4 | 2024-10-23 | 2024-11-29 |
| Analgesic drugs | 2024.1 | 2024-02-14 | 2024-03-15 |
| Analgesic drugs | 2024.2 | 2024-05-08 | 2024-06-07 |
| Analgesic drugs | 2024.3 | 2024-08-14 | 2024-09-13 |
| Analgesic drugs | 2024.4 | 2024-10-23 | 2024-11-22 |
| Antibiotic drugs | 2024.1 | 2024-02-14 | 2024-03-08 |
| Antibiotic drugs | 2024.2 | 2024-05-08 | 2024-05-31 |
| Antibiotic drugs | 2024.3 | 2024-08-14 | 2024-09-06 |
| Antibiotic drugs | 2024.4 | 2024-10-23 | 2024-11-15 |
| Antibiotic drugs 2 | 2024.1 | 2024-04-17 | 2024-06-28 |
| Antibiotic drugs 2 | 2024.2 | 2024-09-25 | 2024-12-06 |
| Antiepileptic drugs | 2024.1 | 2024-02-14 | 2024-03-08 |
| Antiepileptic drugs | 2024.2 | 2024-05-08 | 2024-05-31 |
| Antiepileptic drugs | 2024.3 | 2024-08-14 | 2024-09-06 |
| Antiepileptic drugs | 2024.4 | 2024-10-23 | 2024-11-15 |
| Antiepileptic drugs free concentration | 2024.1 | 2024-02-14 | 2024-03-08 |
| Antiepileptic drugs free concentration | 2024.2 | 2024-05-08 | 2024-05-31 |
| Antiepileptic drugs free concentration | 2024.3 | 2024-08-14 | 2024-09-06 |
| Antiepileptic drugs free concentration | 2024.4 | 2024-10-23 | 2024-11-15 |
| Antifungal drugs | 2024.1 | 2024-03-25 | 2024-05-15 |
| Antifungal drugs | 2024.2 | 2024-06-26 | 2024-08-16 |
| Antifungal drugs | 2024.3 | 2024-08-14 | 2024-10-04 |
| Antifungal drugs | 2024.4 | 2024-10-23 | 2024-12-13 |
| Antiretroviral drugs | 2024.1 | 2024-04-22 | 2024-06-12 |
| Antiretroviral drugs | 2024.2 | 2024-06-26 | 2024-08-16 |
| Antiretroviral drugs | 2024.3 | 2024-08-14 | 2024-10-04 |
| Antiretroviral drugs | 2024.4 | 2024-10-23 | 2024-12-13 |
| Antituberculosis drugs | 2024.1 | 2024-04-17 | 2024-06-28 |
| Antituberculosis drugs | 2024.2 | 2024-09-25 | 2024-12-06 |
| Antiviral drugs | 2024.1 | 2024-03-27 | 2024-05-25 |
| Antiviral drugs | 2024.2 | 2024-08-14 | 2024-10-12 |
| Benzodiazepines | 2024.1 | 2024-02-14 | 2024-03-15 |
| Benzodiazepines | 2024.2 | 2024-05-08 | 2024-06-07 |
| Benzodiazepines | 2024.3 | 2024-08-14 | 2024-09-13 |
| Benzodiazepines | 2024.4 | 2024-10-23 | 2024-11-22 |
| Biologicals | 2024.1 | 2024-03-27 | 2024-05-15 |
| Biologicals | 2024.2 | 2024-06-26 | 2024-08-14 |
| Biologicals | 2024.3 | 2024-08-14 | 2024-10-02 |
| Biologicals | 2024.4 | 2024-10-23 | 2024-12-11 |
| Busulfan | 2024.1 | 2024-06-07 | 2024-07-16 |
| Busulfan | 2024.2 | 2024-11-11 | 2024-12-13 |
| Cardiac drugs | 2024.1 | 2024-02-14 | 2024-03-08 |
| Cardiac drugs | 2024.2 | 2024-05-08 | 2024-05-31 |
| Cardiac drugs | 2024.3 | 2024-08-14 | 2024-09-06 |
| Cardiac drugs | 2024.4 | 2024-10-23 | 2024-11-15 |
| Drugs alternating | 2024.1 | 2024-02-14 | 2024-03-15 |
| Drugs alternating | 2024.2 | 2024-05-08 | 2024-06-07 |
| Drugs alternating | 2024.3 | 2024-08-14 | 2024-09-13 |
| Drugs alternating | 2024.4 | 2024-10-23 | 2024-11-22 |
| Drugs of Abuse | 2024.1 | 2024-02-14 | 2024-03-22 |
| Drugs of Abuse | 2024.2 | 2024-05-08 | 2024-06-14 |
| Drugs of Abuse | 2024.3 | 2024-08-14 | 2024-09-20 |
| Drugs of Abuse | 2024.4 | 2024-10-23 | 2024-11-29 |
| Immunosuppressant microsampling | 2024.1 | 2024-03-18 | 2024-04-28 |
| Immunosuppressant microsampling | 2024.2 | 2024-09-04 | 2024-10-05 |
| Oral oncolytics | 2024.1 | 2024-03-27 | 2024-04-28 |
| Oral oncolytics | 2024.2 | 2024-06-26 | 2024-07-28 |
| Oral oncolytics | 2024.3 | 2024-08-14 | 2024-09-15 |
| Oral oncolytics | 2024.4 | 2024-10-23 | 2024-11-24 |
| Psychotherapeutic drugs | 2024.1 | 2024-02-14 | 2024-03-15 |
| Psychotherapeutic drugs | 2024.2 | 2024-05-08 | 2024-06-07 |
| Psychotherapeutic drugs | 2024.3 | 2024-08-14 | 2024-09-13 |
| Psychotherapeutic drugs | 2024.4 | 2024-10-23 | 2024-11-22 |
| Thiopurines | 2024.1 | 2024-03-13 | 2024-04-12 |
| Thiopurines | 2024.2 | 2024-05-22 | 2024-06-21 |
| Thiopurines | 2024.3 | 2024-08-14 | 2024-09-13 |
| Thiopurines | 2024.4 | 2024-10-23 | 2024-11-22 |
| Toxicology | 2024.1 | 2024-02-14 | 2024-03-22 |
| Toxicology | 2024.2 | 2024-05-16 | 2024-06-22 |
| Toxicology | 2024.3 | 2024-08-14 | 2024-09-20 |
| Toxicology | 2024.4 | 2024-10-23 | 2024-11-29 |
Section: Hematology
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Blood Cell Morphology | 2024.1 | 2024-03-13 | 2024-03-27 |
| Blood Cell Morphology | 2024.2 | 2024-06-05 | 2024-06-19 |
| Blood Cell Morphology | 2024.3 | 2024-10-09 | 2024-10-30 |
| Erythrocyte serology basic | 2024.1 | 2024-01-24 | 2024-02-06 |
| Erythrocyte serology basic | 2024.2 | 2024-04-03 | 2024-04-16 |
| Erythrocyte serology basic | 2024.3 | 2024-09-11 | 2024-09-24 |
| Erythrocyte serology detailed | 2024.1 | 2024-06-04 | 2024-06-17 |
| Erythrocyte serology detailed | 2024.2 | 2024-10-07 | 2024-10-20 |
| Erythrocyte serology pregnancy | 2024.1 | 2024-03-13 | 2024-03-26 |
| Erythrocyte serology pregnancy | 2024.2 | 2024-06-19 | 2024-07-02 |
| Erythrocyte serology pregnancy | 2024.3 | 2024-11-13 | 2024-11-26 |
| Hb variants | 2024.1 | 2024-01-01 | 2024-07-01 |
| Hb variants | 2024.2 | 2024-06-17 | 2024-12-16 |
| Hemocytometry | 2024.1 | 2024-01-18 | 2024-01-19 |
| Hemocytometry | 2024.2 | 2024-03-21 | 2024-03-22 |
| Hemocytometry | 2024.3 | 2024-05-02 | 2024-05-03 |
| Hemocytometry | 2024.4 | 2024-06-13 | 2024-06-14 |
| Hemocytometry | 2024.5 | 2024-09-12 | 2024-09-13 |
| Hemocytometry | 2024.6 | 2024-11-14 | 2024-11-15 |
| Platelets / leukocyte serology | 2024.1 | 2024-01-23 | 2024-02-19 |
Section: Humoral immunology
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Allergy | 2024.1 | 2024-01-23 | 2024-03-06 |
| Allergy | 2024.2 | 2024-03-06 | 2024-05-08 |
| Allergy | 2024.3 | 2024-05-08 | 2024-08-14 |
| Allergy | 2024.4 | 2024-08-14 | 2024-10-30 |
| Allergy Type III antibodies | 2024.1 | 2024-10-09 | 2024-11-09 |
| ANCA-GBM | 2024.1 | 2024-03-12 | 2024-05-15 |
| ANCA-GBM | 2024.2 | 2024-10-01 | 2024-12-04 |
| Antibodies against skin | 2024.1 | 2024-09-17 | 2024-11-05 |
| Blood pigments in cerebrospinal fluid | 2024.1 | 2024-03-13 | 2024-04-20 |
| Blood pigments in cerebrospinal fluid | 2024.2 | 2024-09-18 | 2024-10-26 |
| Celiac disease | 2024.1 | 2024-05-16 | 2024-07-12 |
| Celiac disease | 2024.2 | 2024-10-24 | 2024-12-20 |
| Collagen | 2024.1 | 2024-02-16 | 2024-03-18 |
| Collagen | 2024.2 | 2024-08-14 | 2024-09-14 |
| Complement factors | 2024.1 | 2024-10-14 | 2024-12-10 |
| Diabetes | 2024.1 | 2024-09-11 | 2024-11-12 |
| Liquor protein | 2024.1 | 2024-03-13 | 2024-04-20 |
| Liquor protein | 2024.2 | 2024-09-18 | 2024-10-26 |
| M-protein | 2024.1 | 2024-01-18 | 2024-03-13 |
| M-protein | 2024.2 | 2024-04-11 | 2024-06-05 |
| M-protein | 2024.3 | 2024-06-27 | 2024-08-21 |
| M-protein | 2024.4 | 2024-09-26 | 2024-11-20 |
| PLA2R antibodies | 2024.1 | 2024-04-09 | 2024-05-21 |
| PLA2R antibodies | 2024.2 | 2024-10-08 | 2024-11-19 |
| Plasma proteins | 2024.1 | 2024-01-01 | 2024-04-01 |
| Plasma proteins | 2024.2 | 2024-04-01 | 2024-07-01 |
| Plasma proteins | 2024.3 | 2024-07-01 | 2024-10-01 |
| Plasma proteins | 2024.4 | 2024-10-01 | 2025-01-01 |
| Rheuma | 2024.1 | 2024-04-15 | 2024-05-16 |
| Rheuma | 2024.2 | 2024-10-14 | 2024-11-14 |
| Soluble IL2 receptor | 2024.1 | 2024-05-29 | 2024-06-29 |
| Soluble IL2 receptor | 2024.2 | 2024-10-23 | 2024-11-23 |
| Stomach / Liver antibodies | 2024.1 | 2024-10-09 | 2024-12-12 |
| Thyroid Antibodies | 2024.1 | 2024-04-17 | 2024-06-20 |
| Tryptase | 2024.1 | 2024-10-09 | 2024-11-08 |
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| AML moleculair diagnostics | 2024.1 | 2024-09-03 | 2024-10-14 |
| BCR::ABL1 and AML Translocation Identification | 2024.1 | 2024-04-11 | 2024-05-11 |
| BCR::ABL1 and AML Translocation Identification | 2024.2 | 2024-08-14 | 2024-09-13 |
| BCR::ABL1 and AML Translocation Identification | 2024.3 | 2024-12-01 | 2025-01-01 |
| BCR::ABL1 Kinase Domain Variant (Mutation) Status | 2023.2 | 2024-01-19 | 2024-02-18 |
| BCR::ABL1 Kinase Domain Variant (Mutation) Status | 2023.3 | 2024-03-18 | 2024-04-19 |
| BCR::ABL1 Kinase Domain Variant (Mutation) Status | 2024.1 | 2024-07-11 | 2024-08-16 |
| BCR::ABL1 Kinase Domain Variant (Mutation) Status | 2024.2 | 2024-10-01 | 2024-11-01 |
| BCR::ABL1 Major Quantification | 2023.3 | 2024-01-01 | 2024-02-01 |
| BCR::ABL1 Major Quantification | 2024.1 | 2024-05-15 | 2024-06-14 |
| BCR::ABL1 Major Quantification | 2024.2 | 2024-09-18 | 2024-10-18 |
| BCR::ABL1 Minor Quantification | 2023.3 | 2024-03-08 | 2024-04-04 |
| BCR::ABL1 Minor Quantification | 2024.1 | 2024-06-05 | 2024-07-05 |
| BCR::ABL1 Minor Quantification | 2024.2 | 2024-09-25 | 2024-10-25 |
| Bonemarrow morphology | 2024.1 | 2024-04-29 | 2024-06-13 |
| Bonemarrow morphology | 2024.2 | 2024-10-28 | 2024-12-12 |
| CD34 | 2023.6 | 2024-01-15 | 2024-01-29 |
| CD34 | 2024.1 | 2024-04-30 | 2024-05-14 |
| CD34 | 2024.2 | 2024-07-01 | 2024-07-15 |
| CD34 | 2024.3 | 2024-09-03 | 2024-09-17 |
| CD34 | 2024.4 | 2024-10-01 | 2024-10-15 |
| CD34 | 2024.5 | 2024-12-01 | 2024-12-15 |
| Chimerism | 2024.1 | 2024-01-02 | 2024-01-23 |
| Fetomaternal transfusion | 2024.1 | 2024-03-12 | 2024-03-20 |
| Fetomaternal transfusion | 2024.2 | 2024-09-17 | 2024-09-25 |
| Leukemia/Lymphoma typing | 2024.1 | 2024-04-03 | 2024-04-17 |
| Leukemia/Lymphoma typing | 2024.2 | 2024-06-05 | 2024-06-19 |
| Leukemia/Lymphoma typing | 2024.3 | 2024-08-30 | 2024-09-13 |
| Leukemia/Lymphoma typing | 2024.4 | 2024-11-15 | 2024-11-29 |
| Lymphocyte subsets BAL | 2024.1 | 2024-08-07 | 2024-08-22 |
| Lymphocyte subsets BAL | 2024.2 | 2024-10-31 | 2024-11-15 |
| Lymphocytes Subsets | 2024.1 | 2024-06-03 | 2024-06-17 |
| Lymphocytes Subsets | 2024.2 | 2024-08-13 | 2024-08-27 |
| Lymphocytes Subsets | 2024.3 | 2024-09-01 | 2024-09-15 |
| Lymphocytes Subsets | 2024.4 | 2024-11-01 | 2024-11-15 |
| Measurable Residual Disease for AML by Mol. Meth. | 2024.1 | 2024-09-09 | 2024-10-18 |
| MPN molecular diagnostics | 2024.1 | 2024-04-09 | 2024-05-17 |
| PNH diagnostics | 2024.1 | 2024-03-20 | 2024-04-03 |
| PNH diagnostics | 2024.2 | 2024-06-26 | 2024-07-10 |
| PNH diagnostics | 2024.3 | 2024-09-24 | 2024-10-08 |
Section: Infection serology
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| anti-HBc screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| anti-HBc screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| anti-HBc screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| anti-HBs screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| anti-HBs screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| anti-HBs screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| AST / AntiDNaseB serology | 2024.1 | 2024-06-12 | 2024-07-03 |
| Bartonella henselae serology | 2024.1 | 2024-05-15 | 2024-06-05 |
| Bordetella serology | 2024.1 | 2024-09-25 | 2024-10-16 |
| CMV/EBV/Toxoplasma serology | 2024.1 | 2024-03-13 | 2024-03-27 |
| CMV/EBV/Toxoplasma serology | 2024.2 | 2024-10-18 | 2024-11-01 |
| Exantheme Diseases Diagnostics | 2024.1 | 2024-01-31 | 2024-02-21 |
| HBsAg screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| HBsAg screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| HBsAg screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| HCV screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| HCV screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| HCV screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| Helicobacter pylori (Ag) in feces | 2024.1 | 2024-09-11 | 2024-10-02 |
| Helicobacter serology | 2024.1 | 2024-03-27 | 2024-04-17 |
| Hepatitis ABCE serology | 2024.1 | 2024-05-15 | 2024-06-05 |
| Hepatitis ABCE serology | 2024.2 | 2024-11-20 | 2024-12-11 |
| HIV screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| HIV screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| HIV screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| HIV serology (incl. blot) | 2024.1 | 2024-05-22 | 2024-06-12 |
| HTLV-I screen | 2024.1 | 2024-01-01 | 2024-03-13 |
| HTLV-I screen | 2024.2 | 2024-03-13 | 2024-06-13 |
| HTLV-I screen | 2024.3 | 2024-06-13 | 2024-09-13 |
| Immunity serology | 2024.1 | 2024-07-17 | 2024-08-07 |
| Lues / Lyme serology | 2024.1 | 2024-05-15 | 2024-06-05 |
| Lues / Lyme serology | 2024.2 | 2024-11-27 | 2024-12-18 |
| Lues screen (TPHA) | 2024.1 | 2024-01-01 | 2024-03-13 |
| Lues screen (TPHA) | 2024.2 | 2024-03-13 | 2024-06-13 |
| Lues screen (TPHA) | 2024.3 | 2024-06-13 | 2024-09-13 |
| Respiratory serology | 2024.1 | 2024-10-16 | 2024-11-06 |
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Molecular Biology various | 2024.1 | 2024-03-13 | 2024-04-20 |
| Molecular Biology various | 2024.2 | 2024-09-10 | 2024-10-18 |
| Pharmacogenetics | 2024.1 | 2024-03-13 | 2024-04-20 |
| Pharmacogenetics | 2024.2 | 2024-09-10 | 2024-10-18 |
| Thrombophilia (genetics) | 2024.1 | 2024-03-13 | 2024-04-20 |
| Thrombophilia (genetics) | 2024.2 | 2024-09-10 | 2024-10-18 |
Section: Parasitology
Section: Semen
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Semen analysis | 2024.1 | 2024-02-23 | 2024-03-21 |
| Semen analysis | 2024.2 | 2024-05-10 | 2024-06-06 |
| Semen analysis | 2024.3 | 2024-08-30 | 2024-09-26 |
| Semen analysis | 2024.4 | 2024-11-01 | 2024-11-28 |
Section: Coagulation
| Scheme | Round | Start date | Submit before (00:00 CET) |
|---|---|---|---|
| Coagulation | 2024.1 | 2024-02-05 | 2024-02-10 |
| Coagulation | 2024.2 | 2024-03-25 | 2024-03-30 |
| Coagulation | 2024.3 | 2024-05-06 | 2024-05-11 |
| Coagulation | 2024.4 | 2024-07-01 | 2024-07-06 |
| Coagulation | 2024.5 | 2024-09-02 | 2024-09-07 |
| Coagulation | 2024.6 | 2024-11-04 | 2024-11-09 |
| D-Dimer | 2024.1 | 2024-03-19 | 2024-04-02 |
| D-Dimer | 2024.2 | 2024-06-04 | 2024-06-18 |
| D-Dimer | 2024.3 | 2024-09-03 | 2024-09-17 |
| D-Dimer | 2024.4 | 2024-11-12 | 2024-11-26 |
| PT-INR for oral anticoagulation | 2024.1 | 2024-02-05 | 2024-02-10 |
| PT-INR for oral anticoagulation | 2024.2 | 2024-03-25 | 2024-03-30 |
| PT-INR for oral anticoagulation | 2024.3 | 2024-05-06 | 2024-05-11 |
| PT-INR for oral anticoagulation | 2024.4 | 2024-07-01 | 2024-07-06 |
| PT-INR for oral anticoagulation | 2024.5 | 2024-09-02 | 2024-09-07 |
| PT-INR for oral anticoagulation | 2024.6 | 2024-11-04 | 2024-11-09 |